Abstract Submission Guidelines

We invite researchers, clinicians, and professionals to submit abstracts for presentation at the 3^rd Pediatric Exercise Oncology Congress 2026 – PEOC meets FORTEe, taking place April 16-17, 2026, in Mainz, Germany. Submissions should reflect original work aligned with the congress topics listed below.

Inhaltsverzeichnis

1. Scientific & Social Program Highlights
2. Why Submit?
3. Key Dates
4. Abstract Submission Rules & Limitations
5. Guidelines for Preparing Your Abstract
6. How to Submit an Abstract
7. Overview of Presentation Formats
8. Abstract Topics
9. Selection Process
10. Young Investigator Award
11. Abstract Submitters’ Declaration
12. Contact

Scientific & Social Program Highlights

• Keynote lectures by internationally renowned experts – see preliminary program
• Symposium, Research Presentations, Rapid Oral sessions, and a Poster Reception
• Informal “wine & cheese” networking during the poster session
• Congress Dinner (additional fee)
• Social excursions showcasing local culture and innovation

Why Submit?

• Be part of the first in-person PEOC meets FORTEe event
• Build your network across pediatric exercise oncology
• Gain international recognition for your work

Key Dates

Submit via the official portal: Abstract Submission

Abstract Submission Rules & Limitations

• Abstracts must be submitted online only; e-mail submissions are not accepted.
• No fee is charged for submission.
• Presentation type: Oral or Poster (all presenters must attend in person).
• Maximum 2 abstracts as first/presenting author; unlimited as co-author.
• Work must be unpublished and not previously accepted by meetings > 500 participants.
• After submission, no changes can be made.
• Accepted abstracts will be published in Journal XX.
• All abstracts must be in English and grammatically sound.
• Conflicts of interest must be disclosed in the submission form.

Guidelines for Preparing Your Abstract

1. Prepare the following information:
   • Presenting author – full name, e-mail, affiliation
   • Co-authors – names and affiliations
   • Preferred presentation type: Oral, Poster, or Either
   • Title (≤ 25 words) and abstract text (≤ 250 words)
   • Topic (select from list below)
2. Formatting:
   • Text only – no tables, figures, or bullet points inside the abstract body.
   • Structure your text with the sub-headings: Background & Aims, Methods, Results, Conclusions.
   • Use minimal abbreviations and write disease names without apostrophes (e.g., “Wilms tumour”).
   • Numbers > 999 include a comma (e.g., 2,000); decimal points use a period (4.89).
3. Upon successful submission you will receive an abstract reference number via e-mail.

How to Submit (Converia)

1. Initiate Submission
   Click “Submit an Abstract” on the congress website.
2. Create Account or Log In
   You’ll be redirected to the Converia portal. If you don’t have an account yet, choose Register and fill in your name, institution, and e-mail. If you already have an account, simply log in with your existing credentials.
3. Complete Your Profile
   Ensure all mandatory fields are filled out—especially the contact details of the presenting author.
4. Start a New Abstract
   In the Abstract Submission section, select New Abstract to begin.
5. Enter Authors & Presentation Type
   Add the presenting author and all co-authors (names and affiliations). Then select your preferred format: Oral, Poster, or Either.
6. Provide Title, Topic & Text
   Enter a title (max. 25 words) and the abstract text (max. 250 words). Choose the appropriate topic from the dropdown list.
7. Check Formatting & Upload Attachments
   Ensure there are no tables, figures, or bullet points in the abstract body. If required (e.g., Young Investigator CV), upload any supplementary files.
8. Acknowledge the Declaration
   Read the Abstract Submitters’ Declaration and tick the checkbox to confirm.
9. Preview & Final Check
   Use the preview function to review your submission for accuracy and compliance.
10. Submit & Receive Confirmation
    Click Submit. You’ll see an on-screen confirmation and receive an e-mail with your reference number.
11. Track Your Submission
    Under My Submissions, you can monitor the status until notification of acceptance.

Overview of Presentation Formats

Research Presentation

12-minute oral presentation + 3 min Q&A.
Scheduled: Friday, 17 April 2025 09:00–10:00, 10:45–11:45, 15:15–16:15

Rapid Oral

7-minute talk + 3 min Q&A, ideal for work-in-progress, pilot studies, or early-career research.
Scheduled: Friday, 17 April 2025 13:45–14:45

Poster Presentation

Interactive poster session fostering detailed discussion and networking.
Scheduled: Thursday, 16 April 2025 16:00–17:30

Abstract Topics

All abstracts must relate to physical activity, exercise, or rehabilitation in pediatric/adolescent oncology.

• Intervention research – Designing, testing, evaluating exercise interventions.
• Mechanisms / basic research – Biological & physiological mechanisms of exercise impact.
• Program implementation & evaluation – Real-world feasibility, effectiveness, sustainability.
• Other – Observational studies, reviews, tool development, etc.

Selection Process

All abstracts are anonymised and scored by the Scientific Committee on relevance, quality, originality, and clarity. Decisions are final; presentation slots and content cannot be changed post-submission.

Young Investigator Award

Applicants ≤ 35 years may compete for Best Poster and Best Oral Awards.
Submit a one-page CV and a one-page statement of academic achievements along with your abstract.

Abstract Submitters’ Declaration

By ticking this box, I confirm that:

1. Originality & Prior Presentation

   The submitted work is original and has not been previously published, accepted by, or published in a peer­-reviewed journal or at any scientific meeting with an audience exceeding 500 attendees at the time of abstract submission.

2. Abstract Review & Submission Finality

   I confirm that I have carefully reviewed this abstract and that all information contained herein is accurate.

   I acknowledge that the content cannot be altered after final submission and will be published as submitted.

3. Authorship & Institutional Approval

   All co-authors have reviewed and approved the submission.

   I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract.

4. Copyright & Use of Third-Party Material

   I own the copyright to the submitted content or have obtained all necessary permission to use any third-party material. I accept full responsibility for the content of the abstract and confirm that it does not infringe any intellectual property rights or other third-party rights. Proper attribution is provided where required.

5. Ethics, Consent & Data Protection

   I affirm that all information submitted is accurate, truthful, and compliant with applicable legal and ethical standards.

   Where human participants are involved, appropriate ethics committee approval has been obtained, and informed consent was secured.

   Any personal data are anonymized and handled in accordance with the General Data Protection Regulation (GDPR) or relevant data protection laws.

6. Animal Research & Experimental Studies

   If the submitted work involves the use of animals or other experimental models, I confirm that it was conducted in accordance with relevant institutional, national, and international guidelines for the care and use of laboratory animals. Appropriate ethical approval was obtained where required.

7. Conflicts of Interest

   I have disclosed all actual or potential financial and non-financial conflicts of interest that may be perceived to influence the submitted work.

8. Publication

   I grant permission for the congress organizers to publish the abstract in the abstract book, on the website, and in affiliated journals or proceedings.

9. Registration & Presentation Commitment

   If accepted, I (or a designated co-author) will register by the deadline, pay any applicable fee, and attend the congress to present the work.

10. Data Privacy & Contact Information

    I consent to the storage and processing of my personal data, including contact information, for the purpose of managing the abstract submission and related congress communications. This data will be handled in accordance with applicable data protection laws, including the GDPR.

Contact